Integrating innate and adaptive immunity in the whole animal

Immunological Reviews

Volumn 169, Issue , 1999, Pages 225-239

  Lo, David ^a   Feng, Lili ^a   Li, Li ^a   Carson, Monica J ^a   Crowley, Mary ^a   Pauza, Mary ^a   Nguyen, Andrea ^a   Reilly, Christina R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; GENETIC REGULATION; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL;

EID: 0032811067     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01318.x     Document Type: Article

References (47)

1. 1. Thomas L. Lives of a cell. New York: Viking; 1974.
2. 2. Pugin J, et al. CD14 is a pattern recognition receptor. Immunity 1994;1:509-516.
3. 3. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54:1-13.
4. 4. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
5. 5. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
6. 6. Poltorak A, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
7. 7. Inaba K, et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-1860.
8. 8. Ryseck RP, et al. RelB, a new Rel family transcription activator that can interact with p50-NT-κB. Mol Cell Biol 1992;12:674-684.
9. 9. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
10. 10. Lembecher T, Kistler B, Wirth T. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J 1994;13:4046-4069.
11. 11. Burkly L, et al. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 1995;373:531-536.
12. + dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996;88:4029-4039.
13. 13. Pettit AR, et al. Nuclear localization of RelB is associated with effective antigen-presenting cell function. J Immunol 1997;159:3681-3691.
14. 14. Lo D, Quill H, Burkly L, Scott B, Palmiter RD, Brinster RL. A recessive defect in lymphocyte and/or granulocytes function caused by an integrated transgene. Am J Pathol 1992;141:1237-1246.
15. 15. DeKoning J, DiMolfetto L, Reilly C, Wei Q, Havran W, Lo D. Thymic cortical epithelium is sufficient for the development of mature T cells in RelB-deficient mice. J Immunol 1997;158:2558-2566.
16. 16. DiMolfetto L, Reilly C, Wei Q, Lo D. Dendritic-like cells from RelB mutant mice. Adv Exp Med Biol 1997;417:47-54.
17. 17. Crowley M, Lo D. Targeted gene knockouts: insights into dendritic cell biology. In: Lotze MT, Thomson AW, eds. Dendritic cells: biology and clinical application. San Diego: Academic; 1999. p. 579-593.
18. 18. Gerloni M, Lo D, Zanetti M. DNA immunization in RelB-deficient mice discloses a role for dendritic cells in IgM→IgG1 switch in vivo. Eur J Immunol 1998;28:516-524.
19. 19. Gerloni M, Lo D, Ballou WR, Zanetti M. Immunologic memory after somatic transgene immunozation is positively affected by priming with GM-CSF and does not require bone marrow derived dendritic cells. Eur J Immunol 1998;28:1832-1838.
20. + thymocytes. J Immunol 1994;152:3254-3263.
21. 21. Lo D, Reilly C, Burkly L, DeKoning J, Laufer T, Glimcher L. Thymic stromal cell specialization and the T-cell receptor repertoire. Immunol Res 1997;16:3-14.
22. 22. Laufer TM, DeKoning J, Markowitz JS, Lo D, Glimcher LH. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 1996;382:81-85.
23. 23. Weih F, Lira SA, Bravo R. Overexpression of RelB in transgenic mice does not affect 1κB-α levels: differential regulation of RelA and RelB by the inhibitor protein. Oncogene 1996;12:445-449.
24. 24. Lo D, Reilly CR, Scott B, Liblau R, McDevitt HO, Burkly LC. Antigen presenting cells in adoptively transferred and spontaneous diabetes. Eur J Immunol 1993;23:1693-1698.
25. 25. Tanabe S, et al. Identification of a new mouse α-chemokine, TCA-4, with activity on T lymphocytes and mesangial cells. J Immunol 1997;159:5671-5679.
26. 26. Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998;16:545-568.
27. 27. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
28. 28. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997;151:317-322.
29. 29. Xia Y, Pauza M, Feng L, Lo D. RelB regulation of chemokine expression modulates local inflammation. Am J Pathol 1997;151:375-387.
30. 30. Weih F, et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 1995;80:331-340.
31. 31. Cotran RS, Kumar V, Robbins SL. Robbins pathologic basis of disease. 4th ed. Philadelphia: Saunders; 1989.
32. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-38.
33. 33. Li L, Xia Y, Nguyen A, Feng L, Lo D. Th2 induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J Immunol 1998;161:3128-3135.
34. 34. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
35. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
36. 36. Scott B, et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994;1:73-82.
37. 37. Degermann S, Reilly C, Scott B, Ogata L, von Boehmer H, Lo D. On the various manifestations of spontaneous autoimmune diabetes in rodent models. Eur J Immunol 1994;24:3155-3160.
38. + T cells. Eur J Immunol 1992;22:1013-1022.
39. 39. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 1996;45:1063-1067.
40. 40. Wu A, Schulman SJ, Marconi LA, Reilly C, Scott B, Lo D. Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide. Cell Immunol 1998;184:112-120.
41. 41. Li L, et al. Effect of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by lung epithelial cells. J Immunol 1999;162:2477-2487.
42. 42. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998;55:1139-1149.
43. 43. Carson MJ, Sutcliffe JG. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 1999;55:1-8.
44. 44. Carson MJ, Reilly CR, Sutcliffe JG, Lo D. Mature microglia resemble immature antigen-presenting cells. Glia 1998;22:72-85.
45. + T cells into the central nervous system by professional antigen-presenting cells. Am J Pathol 1999;154:481-494.
46. 46. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568-574.
47. 47. Lo D. Transgenic and knockout models of autoinimunity: building a better disease? Clin Immunol Immunopathol 1996;79:96-104.